Protein kinase C (PKC) isotype profile in eosinophils from ponies with sweet itch and role in histamine-induced eosinophil activation

Veterinary Immunology and Immunopathology

Volumn 96, Issue 1-2, 2003, Pages 53-63

  Greenaway, E C ^a   Sepulveda, M F ^a   Cunningham, F M ^a   Goode, N T ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Equine eosinophils; Histamine; PKC isotypes; Superoxide; Sweet itch

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; HISTAMINE; ISOENZYME; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE C IOTA; PROTEIN KINASE C ZETA; STAUROSPORINE; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; EOSINOPHIL; HORSE; IMMUNOPATHOGENESIS; NONHUMAN; PROTEIN EXPRESSION; PRURITUS;

ANIMALIA; EQUIDAE;

EID: 0141763696     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(03)00161-2     Document Type: Article

References (32)

1. Bailey S.R., Cunningham F.M. Adherence of eosinophils from allergic and normal ponies to cultured equine endothelial cells. Inflamm. Res. 50:2001;32-38.
2. Bankers-Fulbright J.L., Kita H., Gleich G.J., O'Grady S.M. Regulation of human eosinophil NADPH oxidase activity: a central role for PKCδ J. Cell. Physiol. 189:2001;306-315.
3. Bates M.E., Bertics P.J., Calhoun W.J., Busse W.W. Increased protein kinase C activity in low density eosinophils. J. Immunol. 150:1993;4486-4493.
4. Benarafa C., Collins M.E., Hamblin A.S., Cunningham F.M. A role for the chemokine eotaxin in the pathogenesis of equine sweet itch. Vet. Rec. 151:2002;691-693.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
6. Choi E.N., Choi M.K., Park C.-S., Chung I.Y. A parallel signal-transduction pathway for eotaxin- and interleukin-5-induced eosinophil shape change. Immunology. 108:2003;245-256.
7. Dent G., Muňoz N.M., Ruhlmann E., Zhu X., Leff A.R., Magnussen H., Rabe K.F. Protein kinase C inhibition enhances platelet-activating factor-induced eicosanoid production in human eosinophils. Am. Rev. Respir. Cell Mol. Biol. 18:1998;136-144.
8. Egesten A., Malm J. Eosinophil leukocyte degranulation in response to serum-treated opsonized beads: C5a and platelet-activating factor enhance ECP release, with roles for protein kinases A and C. Allergy. 53:1998;1066-1073.
9. Evans, D.J., Lindsay, M.A., Webb, B.L.J., Kankaanranta, H., Giembycz, M.A., O'Connor, B.J., Barnes, P.J., 1999. Expression and activation of protein kinase C-ζ in eosinophils after allergen challenge. Am. J. Physiol. 277 (Lung Cell Mol. Physiol. 21) L233-L239.
10. 4-induced migration of eosinophils and neutrophils isolated from horses with allergic skin disease. Agents Actions. 41:1994;C258-C259.
11. Foster A.P., Cunningham F.M. Differential superoxide anion generation by equine eosinophils and neutrophils. Vet. Immunol. Immunopathol. 59:1997;225-227.
12. Foster A.P., Cunningham F.M. The pathogenesis and immunopharmacology of equine insect hypersensitivity. Adv. Vet. Dermatol. 3:1998;177-189.
13. Foster A.P., Cunningham F.M. Histamine-induced adherence and migration of equine eosinophils. Am. J. Vet. Res. 59:1998;1153-1159.
14. Foster A.P., Lees P., Cunningham F.M. Platelet activating factor mimics antigen-induced cutaneous inflammatory responses in sweet itch horses. Vet. Immunol. Immunopathol. 44:1995;115-128.
15. Foster A.P., Lees P., Cunningham F.M. Actions of PAF receptor antagonists in horses with the allergic skin disease, sweet itch. Inflamm. Res. 44:1995;412-417.
16. Foster A.P., McKelvie J.M., Cunningham F.M. Inhibition of antigen-induced cutaneous responses of ponies with insect hypersensitivity by the histamine-1 receptor antagonist, chlorpheniramine. Vet. Rec. 143:1998;189-193.
17. Gleich G.J. Mechanisms of eosinophil associated inflammation. J. Allergy Clin. Immunol. 105:2000;651-653.
18. Greenaway, E.C., 2001. Protein kinase C in eosinophils from normal and allergic ponies. Ph.D. Thesis. University of London.
19. Greenaway E.C., Cunningham F.M., Goode N.T. Differential localization of protein kinase C isotypes in equine eosinophils and neutrophils. J. Leukocyte Biol. 68:2000;575-582.
20. Gschwendt M., Muller H.J., Kielbassa K., Zang R., Kittstein W., Rincke G., Marks F. Rottlerin, a novel protein kinase inhibitor. Biochem. Biophys. Res. Commun. 199:1994;93-98.
21. Kanashiro C.A., Khalil R.A. Signal transduction by protein kinase C in mammalian cells. Clin. Exp. Pharmacol. Physiol. 25:1998;974-985.
22. Keenan C., Kelleher D. Protein kinase C and the cytoskeleton. Cell. Signal. 10:1998;225-232.
23. Krouwels F.H., Kerstens L.C.M., Van der Maarel H.W.M., Degenhart H.J., Neijens H.J. Density of eosinophils reflects activity of disease in allergic asthmatic children. Clin. Exp. Allergy. 25:1995;1171-1178.
24. Lynch O.T., Giembycz M.A., Barnes P.J., Hellewell P.G., Lindsay M.A. Outside-in signalling mechanisms underlying CD11b/CD18-mediated NADPH oxidase activation in human adherent blood eosinophils. Brit. J. Pharmacol. 128:1999;1149-1158.
25. 4-induced NADPH oxidase activation in adherent and non-adherent guinea-pig eosinophils. Brit. J. Pharmacol. 134:2001;797-806.
26. Martiny-Baron G., Kazanietz M.G., Mischak H., Blumberg P.M., Kochs G., Hug H., Marmé D., Schächtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö6976. J. Biol. Chem. 268:1993;9194-9197.
27. Megson A.C., Walker E.M., Hill S.J. Role of protein kinase C alpha in signalling from the histamine H(1) receptor to the nucleus. Mol. Pharmacol. 59:2001;1012-1021.
28. 2+, protein kinase C and phospholipases C and D. Biochem. J. 310:1995;795-806.
29. 2+ and protein kinase C via distinct mechanisms. EMBO J. 17:1998;4340-4345.
30. Van der Bruggen T., Kok P.T.M., Blom M., Verhoeven A.J., Raaijmakers J.A., Lammers J.W., Koenderman L. Transient exposure of human eosinophils to the protein kinase C inhibitors CGP39-360, CGP41-251, and CGP44-800 leads to priming of the respiratory burst induced by opsonized particles. J. Leukocyte Biol. 54:1993;552-557.
31. Walsh G.M., Dewson G., Wardlaw A.J., Levi-Schaffer F., Moqbel R. A comparative study of different methods for the assessment of apoptosis and necrosis in human eosinophils. J. Immunol. Meth. 217:1998;153-163.
32. Woschnagg C., Garcia R.C., Venge P. The mechanisms of serum-treated zymosan (STZ)-induced oxidative metabolism by human eosinophils and the effects of IL-5 priming. Allergy. 56:2001;639-645.